English
简体中文
Total: £ 56.28
Published Date: 2026-03-30 | Pages: 108 | Tables: 105 | Medical Care
The global Cell Gene Therapy Biomanufacturing market was valued at US$ 16880 million in 2025 and is anticipated to reach US$ 33870 million by 2032, at a CAGR of 10.6% from 2026 to 2032.
Cell and gene therapy (CGT) includes the injection of cells, genes, or gene-modified cells into a patient with the purpose of preventing or treating a disease. Cell therapy involves the injection of cells to replace or aid the repair of damaged cells, whereas gene therapy involves the injection of genes into cells to alter the genetic makeup of the recipient cells. Cell-based gene therapies, such as chimeric antigen receptor T (CAR-T) therapy, represent combinations of both approaches.
In recent years, the demand for cell and gene therapy (CGT) has surged as the number of United States Food and Drug Administration (U.S. FDA)-approved CGT products has increased annually. This increasing demand underscores the pressing need for manufacturers to improve and advance their production processes to keep pace with the rapidly evolving CGT field. The entire CGT manufacturing process must occur in a facility that complies with good manufacturing practice (GMP) regulations and has received full authorization to manufacture CGTs or advanced-therapy medicinal products, as they are referred to in Europe, for human use. Numerous clinical trials have been conducted to assess the safety and efficacy of CGTs for a wide range of clinical indications, including cancer.
This report delivers a comprehensive overview of the global Cell Gene Therapy Biomanufacturing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Gene Therapy Biomanufacturing. The Cell Gene Therapy Biomanufacturing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell Gene Therapy Biomanufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell Gene Therapy Biomanufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Lonza Group
Thermo Fisher Scientific Inc.
Merck KGaA
WuXi AppTec
Catalent, Inc.
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Charles River Laboratories
Cytiva
Novasep
Segment by Type
Consumables
Equipment
Software Solutions
Segment by Application
Life Science Companies
Contract Research Organizations
Contract Manufacturing Organizations
Cell Banks
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell Gene Therapy Biomanufacturing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Consumables
1.2.3 Equipment
1.2.4 Software Solutions
1.3 Market by Application
1.3.1 Global Cell Gene Therapy Biomanufacturing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Life Science Companies
1.3.3 Contract Research Organizations
1.3.4 Contract Manufacturing Organizations
1.3.5 Cell Banks
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Gene Therapy Biomanufacturing Market Perspective (2021–2032)
2.2 Global Cell Gene Therapy Biomanufacturing Growth Trends by Region
2.2.1 Global Cell Gene Therapy Biomanufacturing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell Gene Therapy Biomanufacturing Historic Market Size by Region (2021–2026)
2.2.3 Cell Gene Therapy Biomanufacturing Forecasted Market Size by Region (2027–2032)
2.3 Cell Gene Therapy Biomanufacturing Market Dynamics
2.3.1 Cell Gene Therapy Biomanufacturing Industry Trends
2.3.2 Cell Gene Therapy Biomanufacturing Market Drivers
2.3.3 Cell Gene Therapy Biomanufacturing Market Challenges
2.3.4 Cell Gene Therapy Biomanufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Gene Therapy Biomanufacturing Players by Revenue
3.1.1 Global Top Cell Gene Therapy Biomanufacturing Players by Revenue (2021–2026)
3.1.2 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell Gene Therapy Biomanufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell Gene Therapy Biomanufacturing Revenue
3.4 Global Cell Gene Therapy Biomanufacturing Market Concentration Ratio
3.4.1 Global Cell Gene Therapy Biomanufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Gene Therapy Biomanufacturing Revenue in 2025
3.5 Global Key Players of Cell Gene Therapy Biomanufacturing Head Offices and Areas Served
3.6 Global Key Players of Cell Gene Therapy Biomanufacturing, Products and Applications
3.7 Global Key Players of Cell Gene Therapy Biomanufacturing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell Gene Therapy Biomanufacturing Breakdown Data by Type
4.1 Global Cell Gene Therapy Biomanufacturing Historic Market Size by Type (2021–2026)
4.2 Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Type (2027–2032)
5 Cell Gene Therapy Biomanufacturing Breakdown Data by Application
5.1 Global Cell Gene Therapy Biomanufacturing Historic Market Size by Application (2021–2026)
5.2 Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
6.2 North America Cell Gene Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell Gene Therapy Biomanufacturing Market Size by Country (2021–2026)
6.4 North America Cell Gene Therapy Biomanufacturing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
7.2 Europe Cell Gene Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2021–2026)
7.4 Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
8.2 Asia-Pacific Cell Gene Therapy Biomanufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
9.2 Latin America Cell Gene Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell Gene Therapy Biomanufacturing Market Size by Country (2021–2026)
9.4 Latin America Cell Gene Therapy Biomanufacturing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
10.2 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Details
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Cell Gene Therapy Biomanufacturing Introduction
11.1.4 Lonza Group Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.1.5 Lonza Group Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Cell Gene Therapy Biomanufacturing Introduction
11.3.4 Merck KGaA Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.3.5 Merck KGaA Recent Development
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Details
11.4.2 WuXi AppTec Business Overview
11.4.3 WuXi AppTec Cell Gene Therapy Biomanufacturing Introduction
11.4.4 WuXi AppTec Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.4.5 WuXi AppTec Recent Development
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Details
11.5.2 Catalent, Inc. Business Overview
11.5.3 Catalent, Inc. Cell Gene Therapy Biomanufacturing Introduction
11.5.4 Catalent, Inc. Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.5.5 Catalent, Inc. Recent Development
11.6 Samsung Biologics
11.6.1 Samsung Biologics Company Details
11.6.2 Samsung Biologics Business Overview
11.6.3 Samsung Biologics Cell Gene Therapy Biomanufacturing Introduction
11.6.4 Samsung Biologics Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.6.5 Samsung Biologics Recent Development
11.7 FUJIFILM Diosynth Biotechnologies
11.7.1 FUJIFILM Diosynth Biotechnologies Company Details
11.7.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.7.3 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Introduction
11.7.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.7.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Cell Gene Therapy Biomanufacturing Introduction
11.8.4 Charles River Laboratories Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.8.5 Charles River Laboratories Recent Development
11.9 Cytiva
11.9.1 Cytiva Company Details
11.9.2 Cytiva Business Overview
11.9.3 Cytiva Cell Gene Therapy Biomanufacturing Introduction
11.9.4 Cytiva Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.9.5 Cytiva Recent Development
11.10 Novasep
11.10.1 Novasep Company Details
11.10.2 Novasep Business Overview
11.10.3 Novasep Cell Gene Therapy Biomanufacturing Introduction
11.10.4 Novasep Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.10.5 Novasep Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Consumables
Table 3. Key Players of Equipment
Table 4. Key Players of Software Solutions
Table 5. Global Cell Gene Therapy Biomanufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Cell Gene Therapy Biomanufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Cell Gene Therapy Biomanufacturing Market Size by Region (US$ Million), 2021–2026
Table 8. Global Cell Gene Therapy Biomanufacturing Market Share by Region (2021–2026)
Table 9. Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Cell Gene Therapy Biomanufacturing Market Share by Region (2027–2032)
Table 11. Cell Gene Therapy Biomanufacturing Market Trends
Table 12. Cell Gene Therapy Biomanufacturing Market Drivers
Table 13. Cell Gene Therapy Biomanufacturing Market Challenges
Table 14. Cell Gene Therapy Biomanufacturing Market Restraints
Table 15. Global Cell Gene Therapy Biomanufacturing Revenue by Players (US$ Million), 2021–2026
Table 16. Global Cell Gene Therapy Biomanufacturing Market Share by Players (2021–2026)
Table 17. Global Top Cell Gene Therapy Biomanufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell Gene Therapy Biomanufacturing Revenue, 2025
Table 18. Ranking of Global Top Cell Gene Therapy Biomanufacturing Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Cell Gene Therapy Biomanufacturing Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Cell Gene Therapy Biomanufacturing, Headquarters and Area Served
Table 21. Global Key Players of Cell Gene Therapy Biomanufacturing, Products and Applications
Table 22. Global Key Players of Cell Gene Therapy Biomanufacturing, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Cell Gene Therapy Biomanufacturing Market Size by Type (US$ Million), 2021–2026
Table 25. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Type (2021–2026)
Table 26. Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Type (2027–2032)
Table 28. Global Cell Gene Therapy Biomanufacturing Market Size by Application (US$ Million), 2021–2026
Table 29. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Application (2021–2026)
Table 30. Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Application (2027–2032)
Table 32. North America Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
Table 34. North America Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
Table 47. Lonza Group Company Details
Table 48. Lonza Group Business Overview
Table 49. Lonza Group Cell Gene Therapy Biomanufacturing Product
Table 50. Lonza Group Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 51. Lonza Group Recent Development
Table 52. Thermo Fisher Scientific Inc. Company Details
Table 53. Thermo Fisher Scientific Inc. Business Overview
Table 54. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product
Table 55. Thermo Fisher Scientific Inc. Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 56. Thermo Fisher Scientific Inc. Recent Development
Table 57. Merck KGaA Company Details
Table 58. Merck KGaA Business Overview
Table 59. Merck KGaA Cell Gene Therapy Biomanufacturing Product
Table 60. Merck KGaA Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 61. Merck KGaA Recent Development
Table 62. WuXi AppTec Company Details
Table 63. WuXi AppTec Business Overview
Table 64. WuXi AppTec Cell Gene Therapy Biomanufacturing Product
Table 65. WuXi AppTec Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 66. WuXi AppTec Recent Development
Table 67. Catalent, Inc. Company Details
Table 68. Catalent, Inc. Business Overview
Table 69. Catalent, Inc. Cell Gene Therapy Biomanufacturing Product
Table 70. Catalent, Inc. Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 71. Catalent, Inc. Recent Development
Table 72. Samsung Biologics Company Details
Table 73. Samsung Biologics Business Overview
Table 74. Samsung Biologics Cell Gene Therapy Biomanufacturing Product
Table 75. Samsung Biologics Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 76. Samsung Biologics Recent Development
Table 77. FUJIFILM Diosynth Biotechnologies Company Details
Table 78. FUJIFILM Diosynth Biotechnologies Business Overview
Table 79. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product
Table 80. FUJIFILM Diosynth Biotechnologies Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 81. FUJIFILM Diosynth Biotechnologies Recent Development
Table 82. Charles River Laboratories Company Details
Table 83. Charles River Laboratories Business Overview
Table 84. Charles River Laboratories Cell Gene Therapy Biomanufacturing Product
Table 85. Charles River Laboratories Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 86. Charles River Laboratories Recent Development
Table 87. Cytiva Company Details
Table 88. Cytiva Business Overview
Table 89. Cytiva Cell Gene Therapy Biomanufacturing Product
Table 90. Cytiva Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 91. Cytiva Recent Development
Table 92. Novasep Company Details
Table 93. Novasep Business Overview
Table 94. Novasep Cell Gene Therapy Biomanufacturing Product
Table 95. Novasep Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
Table 96. Novasep Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Cell Gene Therapy Biomanufacturing Picture
Figure 2. Global Cell Gene Therapy Biomanufacturing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cell Gene Therapy Biomanufacturing Market Share by Type: 2025 vs 2032
Figure 4. Consumables Features
Figure 5. Equipment Features
Figure 6. Software Solutions Features
Figure 7. Global Cell Gene Therapy Biomanufacturing Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Cell Gene Therapy Biomanufacturing Market Share by Application: 2025 vs 2032
Figure 9. Life Science Companies Case Studies
Figure 10. Contract Research Organizations Case Studies
Figure 11. Contract Manufacturing Organizations Case Studies
Figure 12. Cell Banks Case Studies
Figure 13. Cell Gene Therapy Biomanufacturing Report Years Considered
Figure 14. Global Cell Gene Therapy Biomanufacturing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Cell Gene Therapy Biomanufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Cell Gene Therapy Biomanufacturing Market Share by Region: 2025 vs 2032
Figure 17. Global Cell Gene Therapy Biomanufacturing Market Share by Players in 2025
Figure 18. Global Cell Gene Therapy Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Cell Gene Therapy Biomanufacturing Revenue in 2025
Figure 20. North America Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Cell Gene Therapy Biomanufacturing Market Share by Country (2021–2032)
Figure 22. United States Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Cell Gene Therapy Biomanufacturing Market Share by Country (2021–2032)
Figure 26. Germany Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Share by Region (2021–2032)
Figure 34. China Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Cell Gene Therapy Biomanufacturing Market Share by Country (2021–2032)
Figure 42. Mexico Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Share by Country (2021–2032)
Figure 46. Israel Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Lonza Group Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 51. Merck KGaA Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 52. WuXi AppTec Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 53. Catalent, Inc. Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 54. Samsung Biologics Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 55. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 56. Charles River Laboratories Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 57. Cytiva Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 58. Novasep Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
